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'e causes of embryological developmental anomalies leading to laryngotracheoesophageal clefts (LTECs) are not
known, but are proposed to be multifactorial, including genetic and environmental factors. Haploinsuﬃciency of
the RERE gene might contribute to diﬀerent phenotypes seen in individuals with 1p36 deletions. We describe a neonate of
an obese mother, diagnosed with type IV LTEC and type III esophageal atresia (EA), in which a 1p36 deletion in-
cluding the RERE gene was detected. On the second day of life, a right thoracotomy and extrapleural esophagus atresia
repair were attempted. One week later, a right cervical approach was performed to separate the cervical esophagus
from the trachea. 'ree months later, a thoracic termino-terminal anastomosis of the esophagus was performed. An
anterior fundoplication was required at 8 months of age due to severe gastroesophageal reﬂux and failure to thrive. A
causal role of 1p36 deletions including the RERE gene in the malformation is proposed. Moreover, additional parental
factors must be considered. Future studies are mandatory to elucidate genomic and epigenomic susceptibility factors that
underlie these congenital malformations. A multiteam approach is a crucial factor in the successful management of
aﬀected patients.
1. Introduction
Complete laryngotracheoesophageal clefts (LTECs), types
III and IV, are rare congenital anomalies that occur when
the primitive foregut fails to separate into the tracheo-
bronchial tree and the esophagus [1]. 'ese malformations
are the most challenging to diagnose and manage since they
are life-threatening conditions [1–6]. LTECs have been
associated with many other congenital anomalies, such as
defects of the gastrointestinal and genitourinary tracts and
cardiovascular anomalies [7]. 'e causes of embryological
developmental anomalies leading to LTECs are not known,
but are proposed to be multifactorial, including genetic and
environmental factors, such as maternal risks [4–6, 8].
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'e arginine-glutamic acid dipeptide repeats gene
(RERE (MIM: 605226)) is located in the proximal 1p36
critical region [9, 10]. RERE encodes a widely expressed
nuclear receptor coregulator [11, 12] that positively regulates
retinoic acid signaling in multiple tissues during embryonic
development [13–15]. Data from animal models suggest that
haploinsuﬃciency of RERE might contribute to intellectual
disability, developmental delay, structural brain anomalies,
vision problems, hearing loss, congenital heart defects,
cardiomyopathy, and renal anomalies seen in individuals
with 1p36 deletions [16]. However, the exact role that RERE
deﬁciency plays in 1p36 deletion syndrome, and more
generally in human disease, remains unclear [9].
We describe a neonate diagnosed with type IV LTEC and
type III esophageal atresia in which a 1p36 deletion in-
cluding the RERE gene was detected. 'e surgical and
anesthesiological decision-making and management of the
newborn are detailed. 'e roles of multifactorial factors in
the pathogenesis of the malformation are also discussed.
2. Case Presentation
A Caucasian male neonate, weighing 3080 g, was born by
cesarean section at the 37th week of pregnancy. Prenatally, at
23 weeks’ gestation, microgastria without polyhydramnios
was detected and a suspicion of type III esophageal atresia
was suggested. Prenatal MRI was not available due to severe
maternal obesity. 'e Apgar scores were 7 and 9 at 1 and 5
minutes, respectively. At birth, clinical examination revealed
hypotonia and pathological transmitted sounds from the
upper airways without respiratory distress. No dysmorphic
features, eye anomalies, vertebral or limb abnormalities, or
genitalia malformations were noted.
A posterior-anterior chest radiograph at 3 h of age
conﬁrmed the prenatal suspicion of esophageal atresia. At
bronchoscopy, type IV LTEC was diagnosed associated with
type III esophageal atresia. Illustration of the malformation
is shown in Figure 1(a).
On the second day of life, a right thoracotomy and
extrapleural esophagus atresia repair were attempted. Fol-
lowing induction, the patient was intubated with a 3.5mm
uncuﬀed endotracheal tube. 'e tracheoesophageal ﬁstula
was sutured ﬁrst. Multiple episodes of desaturation were
immediately controlled after the dissection of the proximal
esophageal pouch from the trachea. 'e neoesophageal tube
was separated from the trachea using running sutures
(Figure 1(b)). A nonresorbable biologic-tissue patch was
positioned in between the anterior esophageal wall and the
trachea in order to consolidate the tracheal pars mem-
branacea. 'e proximal and distal pouches were stitched to
the right thoracic paravertebral region to obtain progressive
elongation. Gastrostomy for feeding was also performed.
One week later, a right cervical approach was per-
formed to separate the cervical esophagus from the trachea
(Figure 1(c)). After surgery, the child was gradually weaned
oﬀ a ventilator, and after 13 days, suﬃcient respiratory
autonomy was obtained. Enteral feeding was started. 'e
postoperative course was characterized by Klebsiella
septicemia, a thromboembolic event and bronchopneu-
monia ab ingestis. 'ree months later, the thoracic
termino-terminal anastomosis of the esophagus was per-
formed (Figure 1(d)). An anterior fundoplication was re-
quired at eight months of age due to severe
gastroesophageal reﬂux and failure to thrive.
Genetic testing and genomic DNA sequencing were
performed. No evidence of cystic ﬁbrosis or phenylketonuria
was detected. CHD7 sequencing and deletion and dupli-
cation analysis did not reveal any pathological variants.
Array-CGH analysis documented a 1p36.33 deletion of
approximately 50 kb (position from 8.779.410 to 8.830.261),
containing the RERE gene. Array-CGH analysis in both
parents showed that the rearrangement was of paternal
origin. 'e child exhibited the associated anomalies, uni-
lateral hypoplastic and ptotic right kidney. No pathological
neurological signs or symptoms were revealed. 'e pro-
band’s father had a normal phenotype but was severely
obese.
3. Discussion
To the best of our knowledge, this is the ﬁrst report on a 1p36
deletion containing the RERE gene in a neonate with type IV
LTEC and type III esophageal atresia. Genetic alterations can
contribute to the development of these congenital malfor-
mations; moreover, the role of environmental factors should
not be excluded.
Subjects with terminal and interstitial deletions of
chromosome 1p36 have a spectrum of defects that include
eye anomalies, postnatal growth deﬁciency, structural brain
anomalies, seizures, cognitive impairment, delayed motor
development, behavior problems, hearing loss, cardiovas-
cular malformations, cardiomyopathy, and renal anomalies
[9, 16]. 'e proximal 1p36 genes that contribute to these
defects have not been clearly delineated. RERE is located in
the proximal region of chromosome 1p36. Due to its role as
a nuclear receptor coregulator and the role it plays in ret-
inoic acid signaling, it is considered a candidate gene, which
could contribute to the development of several phenotypes
seen in individuals with proximal interstitial deletions or
large terminal deletions of 1p36 [9].
'e function of RERE in development has been explored
using mouse models. In these models, RERE plays a critical
role in the development and function of multiple organs
including the eye, brain, inner ear, heart, and kidney. To
date, mutations in RERE have not been implicated as the
cause of a speciﬁc disease or syndrome in humans; however,
in 16% and 13% of the individuals with isolated 1p36 de-
letions that include RERE, orofacial clefts and genitourinary
anomalies have, respectively, been reported [9].
'e estimated annual incidence of LTEC is 1/10,000 to
1/20,000 live births, accounting for 0.2% to 1.5% of con-
genital malformations of the larynx. It is often associated
with other congenital abnormalities (16% to 68%), mostly
malformations of the digestive tract [7]. Our neonate pre-
sented with LTEC associated with esophageal atresia. 'ere
are scattered reports of patients with this association, but the
actual incidence of this particular association is diﬃcult to
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assess because most of the reports regarding this association
are in the form of case reports or limited series [17–21].
It has been hypothesized that LTECs result from the
complex interplay of multiple genes and environmental
factors. In our patient, in whom LTEC and EA were also
associated with a renal anomaly, the paternal origin of the
genetic rearrangement was revealed. Even though the father
had a normal phenotype, the causal role of RERE in mal-
formations is supported. Indeed, the deletions in RERE may
contribute alone or in conjunction with other genetic or
environmental factors to the development of the phenotype
seen in aﬀected subjects [10]. 'e role of maternal obesity as
a candidate cofactor is also proposed.'e eﬀects of maternal
obesity extend to the fetus, with several large population-
based analyses demonstrating independent risks of fetal
neural tube defects, cardiac malformations, and orofacial
clefts. 'e mechanism for the observed association between
obesity and birth defects is not known, but several possible
explanations have been proposed [22]. Firstly, obese women
have metabolic alterations, such as hyperglycemia/diabetes
or elevated insulin or estrogen levels that increase the risk for
birth defects. Secondly, women who are obese also might
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Figure 1: Illustration of the congenital malformation and surgical procedures. (a) Type IV laryngotracheoesophageal clefts (LTEC) and type
III esophageal atresia. (b) Step 1: suture of the tracheoesophageal ﬁstula, dissection of the proximal esophageal pouch from the trachea, and
separation of the neoesophageal tube from the trachea. (c) Step 2: separation of the cervical esophagus from the trachea. (d) Step 3: thoracic
termino-terminal anastomosis of the esophagus (drawn by Dr. Salvatore Amoroso).
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have nutritional deﬁcits, resulting from dieting behaviors or
poor-quality diets that increase their risk for congenital
anomalies. Additionally, obese women might have an in-
creased requirement for certain nutrients (e.g., folic acid)
known to be protective against birth defects. Associations
between maternal obesity, epigenetic alterations, and con-
genital malformations have also been proposed [23, 24].
Finally, also considering the father’s severe obesity, the role
of the epigenetic paternal proﬁle should not be excluded
[25].
'e surgical and anesthesiological management of pa-
tients aﬀected by LTEC is generally complicated and pres-
ents a challenge in the preoperative, perioperative, and
postoperative periods [5]. Recent advances in knowledge,
diagnosis, and, above all, the treatment of LTEC have led to
signiﬁcant improvements in survival and quality of life for
these patients, as obtained in this reported patient. As re-
ported by Chitkara et al., critical factors in the successful
management of these patients include a team-oriented ap-
proach with experience in airway surgery, safe management
of the airway, early and aggressive management of gastric
reﬂux, nutritional sustenance, and early surgical in-
tervention [5].
In summary, we describe a neonate aﬀected by type IV
LTEC and type III esophageal atresia, in which a 1p36
deletion containing the RERE gene was detected and
a multiteam approach resulted in successful surgical treat-
ment. 'e causal role of the genetic proﬁle was proposed;
moreover, the fetal eﬀects of concurrent parental factors
should be considered. Future studies are mandatory to
elucidate genomic and epigenomic susceptibility factors,
which underlie these congenital malformations.
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